Keywords: mochida, profit, growth, steady, fy, japan-based, mid-size
Mochida profit growth steady in FY 2008
Article | 05 June 2009
Japan-based mid-size drugmaker Mochida Pharmaceutical saw a 4% rise in profit during fiscal 2008, due to a small increase in sales.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
